Lv7
5300 积分 2020-11-15 加入
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types
6小时前
已完结
Development and validation of a nomogram for predicting postoperative recurrence-free survival in patients with non-metastatic pathological T3a stage renal cell carcinoma
2个月前
已完结
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
2个月前
已完结
Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?
3个月前
已完结
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
3个月前
已完结
Renal cell carcinoma
4个月前
已完结
Surgical and Oncological Outcomes of Level III–IV Versus Level I–II Inferior Vena Cava Thrombectomy: A Decennial Experience of a High-Volume European Referral Center
5个月前
已完结
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
6个月前
已完结
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions
6个月前
已完结
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
6个月前
已完结
皖公网安备34019202002308
